To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms
NCT06158087 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2024-06-27
Summary
The purpose of this study is to assess safety and effectiveness of the pEGASUS stent system.
Conditions
- Intracranial Aneurysm
Interventions
- DEVICE
-
pEGASUS Stent System
Endovascular intervention with p64/p48 MW HPC pEGASUS Stent System was performed in patients diagnosed with intracranial aneurysms
Sponsors & Collaborators
-
Phenox GmbH
collaborator INDUSTRY -
Beijing Wallaby Medical Technologies Co.,Inc.
collaborator UNKNOWN -
Shanghai Wallaby Medical Technologies Co.,Inc.
lead INDUSTRY
Principal Investigators
-
Jianmin Liu · Changhai Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-29
- Primary Completion
- 2026-02-20
- Completion
- 2026-06-20
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.
NCT03733002 ·Status: UNKNOWN ·Phase: PHASE3
-
Revive AIS Patients ImmeDiately
NCT03007082 ·Status: UNKNOWN
-
Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
NCT06853535 ·Status: RECRUITING ·Phase: PHASE3
-
Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke
NCT04813445 ·Status: UNKNOWN ·Phase: NA
-
Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)
NCT04681651 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT06755944 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II
NCT04516993 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion
NCT06211712 ·Status: RECRUITING ·Phase: NA
-
Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China
NCT06078995 ·Status: RECRUITING
-
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase
NCT04086147 ·Status: COMPLETED ·Phase: PHASE2
-
Endovascular Treatment for eXtra-Large Ischemic Stroke
NCT06388148 ·Status: RECRUITING ·Phase: NA
-
SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
NCT05159947 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642 ·Status: RECRUITING ·Phase: PHASE2
-
A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity
NCT04915729 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke
NCT03726814 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
NCT03552354 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
NCT06241677 ·Status: RECRUITING ·Phase: NA
-
Safety and Preliminary Efficacy of NXL-001 in Patients with Ischemic Stroke
NCT06761183 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction
NCT06344312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
NCT07030621 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema
NCT05399550 ·Status: WITHDRAWN ·Phase: PHASE2
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
NCT03844594 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke
NCT07163702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2